Today: 17 April 2026
Lloyds share price: Buyback filing lands as stock heads into London open after Tuesday slide
11 February 2026
1 min read

Lloyds share price: Buyback filing lands as stock heads into London open after Tuesday slide

London, Feb 11, 2026, 07:45 GMT — Early trading hours in focus.

  • Lloyds comes into Wednesday’s session following a steep drop in the last trading day.
  • The lender rolled out more share buybacks and also laid out terms for its latest euro-denominated notes.
  • Capital returns and UK rate moves are in focus for investors as banks continue to report.

Lloyds Banking Group (LLOY.L) heads into Wednesday’s London session having just disclosed a new buyback move—10 million shares bought for cancellation, according to the lender’s latest filing.

Shares closed Tuesday at 102.80 pence, a drop of 2.33%, well below last week’s intraday high of 114.55p. That move shifts attention to what’s left to drive the rally from this point.

Right now, UK bank stocks are reacting sharply to earnings news and changes in rate expectations. The FTSE 100 slipped 0.3% Tuesday. Barclays dropped 2.5%—despite raising both its profit and targets.

Lloyds laid out final terms for a pair of euro note offerings worth a combined €1.5 billion—split between €750 million in floating-rate callable notes maturing 2030, and another €750 million in fixed-rate reset callable notes set for 2037. Issuers have the option to redeem callable notes ahead of maturity.

Lloyds disclosed in a U.S. buyback filing that it purchased 10 million shares on Feb. 10 via Goldman Sachs International, paying between 101.90 and 104.35 pence apiece. The volume-weighted average worked out to 103.6424 pence. The bank intends to cancel the shares.

The previous day, the bank picked up 7.5 million shares—these too are headed for cancellation—paying a volume-weighted average of 103.3946 pence per share.

Lloyds slotted the buybacks into a larger capital return effort unveiled with its annual results on Jan. 29. The bank showed a 12% bump in 2025 pretax profit, reaching £6.7 billion, and bumped its 2026 return on tangible equity target to above 16%—that’s profit measured against tangible book value. CEO Charlie Nunn pointed to the bank’s “momentum”, saying it would “enable us to upgrade guidance”. Reuters

There’s a lingering sense among some investors that the sector’s unusually favorable run isn’t over yet. “UK banks have benefited from earnings resilience lasting longer than initially expected,” said Peter Rothwell, head of banking at KPMG UK. Reuters

Lloyds’ ADR (LYG) ended after-hours trading in New York at $5.79, off by 9.5 cents.

Still, sentiment could sour fast if rate bets change course. UK banks have been working to grow fee income, hoping it offsets a likely slide in interest revenue as rates come down. A more aggressive move could put fresh pressure on investor faith in buyback plans and dividends.

Lloyds’ next big date is Feb. 13, when its 2025 annual report and accounts land. Eyes are also on the ongoing buyback headlines—and whether shares manage to stick close to the £1 level after Tuesday’s decline.

Stock Market Today

  • Nufarm ASX Share Rises on Strong 2026 EBITDA Guidance despite Lower Forecast
    April 16, 2026, 10:07 PM EDT. Nufarm (ASX: NUF) issued first-half fiscal 2026 underlying EBITDA guidance of $239-$244 million, marking a 17% increase from 2025 but below prior $265 million forecasts. Shares jumped 11% on the positive outlook. Gains stem from better crop protection margins, hybrid seed growth, omega-3 recovery, and bioenergy segments. Net debt fell 10% to $1.2 billion, with a net debt to EBITDA ratio of 2.4, improving by 20%. The company expects full-year net debt/EBITDA below 2.0. Despite challenges from previous omega-3 losses and competitive global markets, Nufarm's shares trade at a discount to its $3.50 fair value, reflecting a 16% EBITDA CAGR through 2030. Demand growth in sustainable agriculture and emerging markets underpins its expansion and profitability prospects.

Latest article

Hims & Hers Health Stock Jumps as FDA Reconsiders Peptide Restrictions

Hims & Hers Health Stock Jumps as FDA Reconsiders Peptide Restrictions

16 April 2026
Hims & Hers Health shares rose to $26.65 Thursday after the FDA said it would reconsider restrictions on several peptides, removing 12 from a high-risk list and scheduling a July review of seven more. The move follows Hims’ March decision to stop advertising compounded GLP-1 drugs and expand branded offerings through Novo Nordisk. The company acquired a California peptide facility last year to bolster supply.
NuScale Power Stock Whipsaws After U.S. Opens Door to Nuclear Loans, Space Reactor Push

NuScale Power Stock Whipsaws After U.S. Opens Door to Nuclear Loans, Space Reactor Push

16 April 2026
NuScale Power shares jumped to $13.23 before falling back to $11.52 Thursday after the White House ordered NASA to start a space-reactor program and Energy Secretary Chris Wright said initial U.S. reactors would likely get federal loans. NuScale remains the only U.S. firm with an approved small modular reactor design but has yet to secure firm orders or financing.
SoFi Technologies Stock Rises as FedNow Instant Transfers Set Up April 29 Earnings Test

SoFi Technologies Stock Rises as FedNow Instant Transfers Set Up April 29 Earnings Test

16 April 2026
SoFi Technologies shares rose 1.5% Thursday after launching instant bank transfers via its Galileo platform, allowing money to move between SoFi and outside banks in seconds. The stock traded near $19.08 in New York. Investors await first-quarter results April 29, with SoFi guiding to $1.04 billion in adjusted net revenue and 12 cents per share in adjusted earnings.
D-Wave Quantum Stock Jumps Again as Nvidia’s Ising Launch Reignites Quantum Rally

D-Wave Quantum Stock Jumps Again as Nvidia’s Ising Launch Reignites Quantum Rally

16 April 2026
D-Wave Quantum shares climbed about 5% Thursday, extending a 22.6% surge after Nvidia launched Ising, a new AI model family for quantum computing. D-Wave traded at $21.81, up from last year’s lows, and reported 2025 revenue of $24.6 million with first-quarter 2026 bookings topping $32.8 million. The company completed its $250 million Quantum Circuits acquisition in January. Market cap stood near $8.4 billion.
Morgan Stanley stock slides as AI tax tool spooks wealth managers
Previous Story

Morgan Stanley stock slides as AI tax tool spooks wealth managers

London Stock Exchange Group (LSEG) share price jumps on Elliott stake report as buyback debate flares up
Next Story

London Stock Exchange Group (LSEG) share price jumps on Elliott stake report as buyback debate flares up

Go toTop